IRIS
PREVITI, Santo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.503
EU - Europa 1.431
AS - Asia 1.099
SA - Sud America 427
AF - Africa 34
OC - Oceania 4
Totale 4.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.455
SG - Singapore 495
IT - Italia 388
BR - Brasile 374
IE - Irlanda 300
CN - Cina 239
HK - Hong Kong 193
SE - Svezia 179
PL - Polonia 177
VN - Vietnam 83
FR - Francia 76
AT - Austria 69
DE - Germania 66
GB - Regno Unito 41
RU - Federazione Russa 33
BE - Belgio 28
MX - Messico 25
FI - Finlandia 23
AR - Argentina 21
CA - Canada 17
IN - India 15
NL - Olanda 12
BD - Bangladesh 11
IQ - Iraq 11
MA - Marocco 11
TR - Turchia 10
UA - Ucraina 9
CO - Colombia 8
EC - Ecuador 8
UZ - Uzbekistan 8
ES - Italia 6
ZA - Sudafrica 6
ID - Indonesia 5
CL - Cile 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
JP - Giappone 4
LT - Lituania 4
PE - Perù 4
PY - Paraguay 4
AU - Australia 3
AZ - Azerbaigian 3
KR - Corea 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
VE - Venezuela 2
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 4.498
Salva come PNG Salva come JPEG
Città #
Dublin 300
Chandler 251
Singapore 237
Ashburn 222
Hong Kong 193
Warsaw 175
Nyköping 148
Messina 146
Beijing 115
Dallas 115
Vienna 61
Princeton 50
Los Angeles 41
Ann Arbor 38
Medford 34
Redondo Beach 33
Des Moines 30
Ho Chi Minh City 29
São Paulo 25
Hanoi 20
Aversa 19
New York 19
Jacksonville 18
Brussels 16
Dearborn 16
Montpellier 16
Munich 16
Rome 16
Brasília 15
Cambridge 14
Frankfurt am Main 14
Modica 14
Buffalo 13
Santa Clara 13
Houston 12
San Mateo 12
Belo Horizonte 10
Montreal 10
Bari 9
Boston 9
Jinan 9
Moscow 9
Rio de Janeiro 9
The Dalles 9
Brooklyn 8
Catania 8
Curitiba 8
Ixelles-Elsene 8
London 8
Mexico City 8
San Francisco 8
Tashkent 8
Bexley 7
Chennai 7
Denver 7
Helsinki 7
Lauterbourg 7
Siderno 7
Stockholm 7
Tianjin 7
Wilmington 7
Baghdad 6
Berlin 6
Campinas 6
Francavilla di Sicilia 6
Haikou 6
Phoenix 6
Querétaro 6
Shenyang 6
Taizhou 6
Atlanta 5
Biên Hòa 5
Boardman 5
Chicago 5
Francofonte 5
Goiânia 5
Nuremberg 5
Poplar 5
Portsmouth 5
Riposto 5
Southampton 5
Amsterdam 4
Ankara 4
Borghetto Santo Spirito 4
Brno 4
Cagliari 4
Dong Ket 4
Hangzhou 4
Lima 4
Medellín 4
Porto Alegre 4
Salvador 4
Seattle 4
São José dos Campos 4
Tokyo 4
Zhengzhou 4
Caltagirone 3
Da Nang 3
Falls Church 3
Florence 3
Totale 2.888
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological evaluation of novel inhibitors of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense, as antitrypanosomal agents 290
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 131
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 129
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 123
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 115
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 106
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 105
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 105
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 103
Evaluation of curcumin irreversibility 102
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 101
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 98
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 98
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 97
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 97
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 95
Development of novel amides as non covalent inhibitors of immunoproteasome 91
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 91
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 91
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 88
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 86
Design, synthesis and biological evaluation of potent rhodesain inhibitors as antitrypanosomal agents 85
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 85
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 85
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 81
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 80
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 79
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 78
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 75
Neurotensin, a multi-faceted peptide 75
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 74
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 72
Optimization of radiopharmaceuticals based on neurotensin[8-13] for NTS1-positive tumours imaging 69
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 68
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 64
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 63
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 62
Falcipain-2 and Falcipain-3 inhibitors as promising antimalarial agents 60
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 59
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 58
Silicon-containing neurotensin analogues as radiopharmaceuticals for NTS1-positive tumors imaging 56
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense 56
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 56
Monoclonal antibodies: the greatest resource to treat multiple myeloma 55
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 53
Structure-based design of melanocortin 4 receptor ligands based on the SHU-9119-hMC4R cocrystal structure 53
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 51
Dual inhibition of parasitic targets: a valuable strategy to treat malaria and neglected tropical diseases 50
Identification of dual inhibitors targeting main protease (Mpro) and cathepsin L as potential anti-SARS-CoV‑2 agents 50
null 50
Optimized opioid-neurotensin multitarget peptides: from design to structure−activity relationship studies 50
Design, synthesis, and biological evaluation of the first radio-metalated neurotensin analogue targeting neurotensin receptor 2 42
Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-induced protective hypothermia 41
The inhibition of NS2B/NS3 protease: a new therapeutic opportunity to treat Dengue and Zika virus infection 40
Identification of constrained peptidomimetics carrying a Michael acceptor warhead as antitrypanosomal agents 40
Design, synthesis, and in vitro characterization of proteolytically-stable opioid-neurotensin hybrid peptidomimetics 36
Development of peptide-based SARS CoV-2 Mpro/hCatL dual inhibitors as antiviral agents 36
Design and synthesis of opioid-neurotensin hybrid peptidomimetics: analgesics with reduced side effect profiles 33
Synthesis and Combination Studies of Novel Dipeptide Nitriles with Curcumin for a Potent Synergistic Action Against Rhodesain, Cysteine Protease of Trypanosoma brucei rhodesiense 32
null 27
Design and synthesis of 68Ga-labeled peptide-based heterodimers for dual targeting of NTS1 and GRPR 26
null 22
null 22
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia 20
The Role of Nutraceuticals in Chemoprevention and their Therapeutic Effects when Used in Combination with Synthetic Drugs 18
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management 15
Hybrid synthetic approach and biological characterization of a branched heterodimer for overcoming prostate cancer heterogeneity 14
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 13
Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics 11
Supplement: 37th European Peptide Symposium 14th International Peptide Symposium August 25–August 29, 2024 | Florence, Italy 9
A second opportunity for the peptide-based analogues with γ-lactam at the P1 position: human cathepsin S inhibition 7
CAR-T cell therapy for prostate cancer: current advances and future perspectives 6
Inhibitors of proteases: a well-grounded strategy in drug development 6
N-Terminal stabilization of radiolabeled neurotensin analogues for improved tumor uptake 5
Totale 4.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 30 14 11 49 23 8 7
2021/2022295 6 30 3 23 9 7 44 8 3 20 20 122
2022/2023981 62 94 42 77 55 103 47 78 364 4 48 7
2023/2024319 43 47 18 60 45 11 7 6 2 29 33 18
2024/20251.182 30 9 23 94 41 22 76 195 272 80 129 211
2025/20261.247 162 209 231 290 332 23 0 0 0 0 0 0
Totale 4.815